• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC HEART VALVES DIVISION RING TRI-AD 900SFC26; RING, ANNULOPLASTY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC HEART VALVES DIVISION RING TRI-AD 900SFC26; RING, ANNULOPLASTY Back to Search Results
Model Number 900SFC26
Device Problem Insufficient Information (3190)
Patient Problems Death (1802); Hypovolemic Shock (1917); Blood Loss (2597)
Event Date 04/05/2018
Event Type  Death  
Manufacturer Narrative
Citation: jung w et al.Early clinical outcomes of tricuspid valve repair with a tri-ad annuloplasty ring in comparison with the outcomes using an mc3 ring.Korean j thorac cardiovasc surg.2018 apr;51(2):92-99.Doi: 10.5090/kjtcs.2018.51.2.92.Epub 2018 apr 5.Earliest date of publish used for event date and death date.No unique device identifier (serial/lot) numbers were provided; without this information it could not be determined whether these observations have been previously reported.Without return of the product no definitive conclusion can be made regarding the clinical observations.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Medtronic received information via literature regarding a comparison of the early outcomes in patients who underwent tricuspid valve annuloplasty with a tri-ad ring or an mc3 ring.All data were retrospectively collected from a single center between january 2007 and march 2017.The study population included 229 patients and was predominantly male with a mean age of 59 years.Of those, 36 were implanted with medtronic tri-ad annuloplasty rings.No serial numbers were provided.Among all tri-ad patients, one operative death occurred due to unidentified bleeding and hypovolemic shock.Based on the available information, medtronic product may have been associated with the death.Among all tri-ad patients, adverse events included: reoperation due to bleeding, low cardiac output syndrome, stroke, atrial fibrillation, moderate-severe pulmonary hypertension, mild-moderate-severe tricuspid regurgitation, and moderate-severe left ventricle dysfunction (left ventricular ejection fraction less than 40%).Based on the available information, medtronic product was associated with the adverse events.No additional adverse patient effects or product performance issues were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RING TRI-AD 900SFC26
Type of Device
RING, ANNULOPLASTY
Manufacturer (Section D)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer (Section G)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer Contact
paula bixby
8200 coral sea street ne
mounds view, MN 55112
7635055378
MDR Report Key9856621
MDR Text Key184174299
Report Number2025587-2020-00864
Device Sequence Number1
Product Code KRH
Combination Product (y/n)N
Reporter Country CodeKS
PMA/PMN Number
K093903
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,l
Reporter Occupation Physician
Type of Report Initial
Report Date 03/19/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/19/2020
Is this an Adverse Event Report? Yes
Device Operator Health Professional
Device Model Number900SFC26
Device Catalogue Number900SFC26
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/25/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death;
Patient Age59 YR
-
-